Microbial Genomics Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 2.46 Billion |
| Market Size (2030) | USD 4.58 Billion |
| CAGR (2025 - 2030) | 13.23% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Microbial Genomics Market Analysis
The Microbial Genomics Market size is estimated at USD 2.46 billion in 2025, and is expected to reach USD 4.58 billion by 2030, at a CAGR of 13.23% during the forecast period (2025-2030).
The major factors contributing to the market growth of microbial genomics such as the rising prevalence of infectious diseases and advancements in genomic technologies.
The increasing prevalence of infectious diseases fuels the need to understand pathogens on a genetic basis, particularly in response to infectious diseases such as human immunodeficiency virus (HIV) and pneumonia, has heightened the demand for microbial genomics. For instance, according to the data published by the World Health Organization (WHO) in July 2024, mentioned that around 39.9 million people (ranging from 36.1 to 44.6 million) were living with human immunodeficiency virus (HIV) in 2023 across the world. Additionally, the data published by the World Health Organization (WHO) in November 2023, reported that there are more than 1,400 pneumonia cases for every 100,000 children, accounted to approximately 1 case for every 71 children each year worldwide. Moreover, the same source reported that the highest rates of pneumonia cases were found in South Asia, with 2,500 cases per 100,000 children, followed by West and Central Africa, where the incidence is 1,620 cases per 100,000 children. Thus, the high prevalence of infectious diseases in the world boosts the demand for microbial genomics for genomic sequencing of pathogens and understanding transmission patterns, is anticipated to boost the market growth.
Market player initiatives such as product development which enable researchers to sequence microbial genomes quickly is likely to be adopted and thus contributes to the market growth. For instance, in October 2024, Illumina, Inc. introduced its MiSeq i100 Series of sequencing systems, which provide exceptional benchtop speed and ease of use to enhance next-generation sequencing (NGS) capabilities in laboratories. This system was designed for small whole-genome sequencing in microbiology and targeted NGS panels for infectious diseases and oncology. Additionally, in February 2024, Atrandi Biosciences launched the flux microfluidic system along with the single-microbe DNA barcoding Kit which enables the labeling of up to 10,000 microbial genomes in a single experiment, facilitating high-throughput applications in microbial genomics. In conjunction with this launch, the company also offered a proof-of-concept program that allows microbiology researchers to evaluate the feasibility of high-throughput single-cell DNA sequencing on their samples. Thus, such initiatives adopted by the market players are likely to boost the microbial genomics market growth over the forecast period.
Therefore, the rising incidence of infectious diseases such as human immunodeficiency virus (HIV) and pneumonia, in combination with market player initiatives are key drivers of the microbial genomics market growth. However, the complexity in data analysis and interpretation and lack of standardization may impede the studied market's growth during the forecast period.
Microbial Genomics Market Trends
The Sequencing Segment is Anticipated to Occupy a Largest Market Share in the Microbial Genomics Market During the Forecast Period
Various sequencing technologies, such as next-generation sequencing (NGS) and single-molecule real-time (SMRT) sequencing, among others, are essential in the microbial genomics market. These technologies facilitate identifying, analyzing, and monitoring microbial populations, genomes, and genetic functions. Therefore, the sequencing technology segment is anticipated to hold a significant market share in the studied market.
Major factors drive the sequencing segment growth, including technological advancements, rising demand for personalized medicine, and growing awareness of microbiome research.
Significant advancements in NGS technologies have resulted in quicker and more precise sequencing, enabling researchers to carry out extensive microbial genomic studies more efficiently and is likely to fuel the segment growth. For instance, an article published in the Journal of Biology in April 2024 mentioned that NGS is anticipated to be crucial in fields such as single-cell genomics, long-read sequencing, epigenomics, and multi-omics integration, facilitating a more profound comprehension of cellular processes, disease mechanisms, and personalized treatment approaches. Additionally, the same source reported that targeted NGS panels developed from whole genome sequencing (WGS), while whole exome sequencing (WES) has facilitated the concurrent assessment of numerous genes and their variants. This advancement has allowed for tailored treatment options via personalized genomic testing, contributing to improved human health, preventive care, and effective disease management. Thus, such advancements in NGS technologies are likely to be adopted by researchers in microbial genomics, boosting the segment growth.
Major applications of sequencing in microbial genomics, including pathogen identification and antibiotic resistance profiling, are expected to drive the segment growth. For instance, an article published in Frontiers in Microbiology in January 2024 reported that NGS allows for the classification of bacterial species by examining 16S rRNA-related reads, which enables researchers to investigate complex microbial communities effectively. Additionally, a study published in Nature Communications in June 2024 mentioned that real-time nanopore sequencing can identify antibiotic resistance in pathogens that standard methods like MALDI-TOF MS and VITEK 2. Thus, the wide applications of sequencing in microbial genomics are likely to boost segment growth.
Therefore, the above-mentioned factors, such as rising technological advancements and increasing applications of sequencing in microbial genomics, are likely to fuel the segment's growth during the forecast period.
North America is Anticipated to Occupy the Largest Share in the Microbial Genomics Market Over the Forecast Period
The North America region is anticipated to hold the largest share in the studied market owing to the factors such as robust research infrastructure, technological advancements and rising awareness of microbiome research.
The increasing research activities in microbial genomics is anticipated to contribute to the market growth in the region. For instance, in August 2024, a novel method known as barcoded overexpression bacterial shotgun library sequencing, or Boba-seq, was created at Lawrence Berkeley National Laboratory (Berkeley Lab). This technique will significantly simplify the process for researchers to uncover the traits or activities associated with genes of unknown function in microorganisms, which is an essential step in understanding the roles and effects of specific species. Additionally, in September 2024, the Albert Einstein College of Medicine received grant of USD 14 million from the National Institute of Allergy and Infectious Diseases (NIAID) to contribute to a comprehensive national initiative aimed at creating "plug-and-play" vaccines and antibody-based treatments targeting a variety of emerging viruses. The consortium named PROVIDENT (Prepositioning Optimized Strategies for Vaccines and Immunotherapeutics Against Diverse Emerging Infectious Threats) is focused on discovering and analyzing virus-host interactions as well as the molecular mechanisms linked to viral diseases. Thus, such research activities are anticipated to contribute to the market growth in the region.
Research institutes are highly focused on microbial genomics, thus boosting the market growth in the region. For instance, in September 2023, researches from Harvard Medical School funded with USD 104 million by the United States Department of Health and Human Services to investigate bacterial cells, analyze their genotypes on an individual basis, and examine antibiotic resistance. Thus, such initiatives taken by the government to boost research activities associated with microbial genomics is anticipated to fuel the market growth in the region.
Therefore, owing to the above-mentioned factors, such as the increasing research activities and product developments, fuel the market growth of microbial genomics in the North America region over the forecast period.
Microbial Genomics Industry Overview
The microbial genomics market is considered as fragmented, with specific segments including healthcare, biotechnology, and pharmaceuticals, among others. Companies in this sector focus on innovations and other strategies such as collaborations. Major market players in this market include Illumina, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc, Qiagen N.V. and BioMérieux, among others.
Microbial Genomics Market Leaders
-
Illumina, Inc.
-
Thermo Fisher Scientific Inc.
-
Oxford Nanopore Technologies plc
-
Qiagen N.V.
-
BioMérieux
- *Disclaimer: Major Players sorted in no particular order
Microbial Genomics Market News
- April 2024: CosmosID unveiled new long-read and hybrid bacterial genome sequencing services for thorough genome assembly and analysis in the United States.
- April 2024: Oxford Nanopore technologies Plc introduced a new protocol called Nanopore-Only Microbial Isolate Sequencing Solution (NO-MISS), which offers a complete workflow for sequencing entire microbial isolate genomes. This solution encompasses all stages from DNA extraction to thorough data analysis, specifically tailored for the infectious disease community.
Microbial Genomics Industry Segmentation
According to the scope, microbial genomics focuses on examining the genetic material found in microorganisms, including bacteria, viruses, fungi, and archaea. This field encompasses the sequencing, analysis, and interpretation of these microbes' genomes to gain insights into their genetic makeup, functional roles, and evolutionary connections and serves as an essential tool in the areas of microbial ecology, metagenomics, and research on infectious diseases.
The microbial genomics market is segmented by technology, products and service, application, end-user and geography. By technology, the market is segmented into sequencing, polymerase chain reaction (PCR), microarray technology, nucleic acid extraction and purification and other techniques. By products and service, the market is segmented into consumables, systems and software and services. By application, the market is segmented into diagnostics, drug discovery, biotechnology and other applications. By end-user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes and other end-users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of USD value.
| By Technology | Sequencing | ||
| Polymerase Chain Reaction (PCR) | |||
| Microarray Technology | |||
| Nucleic Acid Extraction and Purification | |||
| Other Techniques | |||
| By Products and Service | Consumables | ||
| Systems and Software | |||
| Services | |||
| By Application | Diagnostics | ||
| Drug Discovery | |||
| Biotechnology | |||
| Other Applications | |||
| By End-User | Hospitals and Diagnostic Laboratories | ||
| Pharmaceutical and Biotechnology Companies | |||
| Academic and Research Institutes | |||
| Other End-Users | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Microbial Genomics Market Research FAQs
How big is the Microbial Genomics Market?
The Microbial Genomics Market size is expected to reach USD 2.46 billion in 2025 and grow at a CAGR of 13.23% to reach USD 4.58 billion by 2030.
What is the current Microbial Genomics Market size?
In 2025, the Microbial Genomics Market size is expected to reach USD 2.46 billion.
Who are the key players in Microbial Genomics Market?
Illumina, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc, Qiagen N.V. and BioMérieux are the major companies operating in the Microbial Genomics Market.
Which is the fastest growing region in Microbial Genomics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Microbial Genomics Market?
In 2025, the North America accounts for the largest market share in Microbial Genomics Market.
What years does this Microbial Genomics Market cover, and what was the market size in 2024?
In 2024, the Microbial Genomics Market size was estimated at USD 2.13 billion. The report covers the Microbial Genomics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Microbial Genomics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Microbial Genomics Industry Report
Statistics for the 2025 Microbial Genomics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Microbial Genomics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
